Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-01-09
DOI
https://doi.org/10.3389/fonc.2025.1730382
Primary Topic
Growth Hormone and Insulin-like Growth Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer

Bo Fang, Ze Fang, Hui Xiao
Frontiers in Oncology
Growth Hormone and Insulin-like Growth Factors
article

Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer

Bo Fang, Ze Fang, Hui Xiao
article en

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 15
Zhongshan People's Hospital (CN), Qujiang People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 94%
Growth Hormone and Insulin-like Growth Factors
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer — Bo Fang, Ze Fang, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS